Skip to content

Clinical trials

Phase 2 Ovarian Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2 Country / region: Russia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20083
20092
20121
20131
20151
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Hoffmann-La Roche3
AstraZeneca2
Glycotope GmbH1
Incyte Corporation1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Merck Sharp & Dohme LLC1
NewVac LLC1
Russian Academy of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms14
Fallopian Tube Neoplasms3
Neoplasms3
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma, Ovarian Epithelial1
Colorectal Neoplasms1
Glioblastoma1
Pancreatic Neoplasms1
Peritoneal Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.